share_log

Wedbush Reiterates Outperform on Adicet Bio, Maintains $5 Price Target

Moomoo 24/7 ·  Apr 23 12:29

Wedbush analyst Robert Driscoll reiterates Adicet Bio (NASDAQ:ACET) with a Outperform and maintains $5 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment